Print this page
Intestamin®
Intestamin®
Features
- Patented Formula
- High in glutamine in the form of dipeptides (30 g/RDD*)
- High in antioxidants: vitamins C and E, ß-carotene, zinc and selenium
- With tributyrin, a precursor of butyrate
- Low daily dosage (500 ml)
- Suitable only for supplementary nutrition
- Fibre-free
- Unflavoured
* RDD = Recommended daily dosage
Indications
For critically ill patients with or at risk of SIRS** or sepsis and with:
- Severe or multiple trauma
- Major abdominal surgery
- Malnourishment
- Serious burns
- Acute severe pancreatitis
** SIRS = systemic inflammatory response syndrome
Packaging
500 ml EasyBag
Dosage
| Recommended daily dosage | ||
|
For supplementary nutrition |
500 ml |
250 kcal |
|
The product is not suitable as a sole source of nutrition. Therefore addition of enteral tube feeds or parenteral solutions is mandatory! |
||
Product Characteristics
| Energy density | 0.5 kcal/ml |
| Key nutrients | |
| Glutamine | 6 g/100 ml |
| Vitamin C | 300 mg/100 ml |
| Vitamin E | 100 mg/100 ml |
| ß-carotene | 2 mg/100 ml |
| Zinc | 4 mg/100 ml |
| Selenium | 60 μg/100 ml |
| Tributyrin | 200 mg/100 ml |
Library
Schroeder J., Alteheld B., Stehle P., Cayeux M-C., Chioléro R.L., Berger M.M.
Safety and intestinal tolerance of high-dose enteral antioxidants and glutamine peptides after upper gastrointestinal surgery
European Journal of Clinical Nutrition (2005) 59, p. 307–310
READ MORE (0.1 MB)
Soguel L., Chioléro R., Revelly J.P., Eggimann P., Berger M.M.
Testing a glutamine selenium and zinc containing enteral supplement after major trauma and burns – preliminary data
Abstract SSMI / SGI
READ MORE (0.2 MB)
Fürst P., Martindale R.G., Biesalski H.K., Suchner U.
Symposium on "Early enteral nutrition of the critically ill - advantages and pitfalls".
Abstractbook Fresenius Kabi
READ MORE (0.3 MB)
Kudlich T.
Intestamin inhibits proliferation and induces differentiation in colorectal carcinoma and adenoma cell lines.
Clinical Nutrition 2003; Vol. 22 (Suppl. 1), p. 75
READ MORE (41 KB)
Berger M.M. Goette J., Stehle P., Cayeux M., Chiolero R., Schroeder J.
P-133 Safety and tolerance of an early enteral antioxidant and glutamine solution after major upper gastrointestinal surgery.
Clinical Nutrition 2002; Vol. 21, p. 73 (Suppl. 1)
READ MORE (22 KB)
Berger M.M. Goette J., Stehle P., Cayeux M., Chiolero R., Schroeder J.
P-073 Enteral absorption of a solution with high dose antioxidants and glutamine early after major upper gastrointestinal surgery.
Clinical Nutrition 2002; Vol. 21, p. 17 (Suppl. 1)
READ MORE (35 KB)
Senkal M., Deska T., Hummel T., Steinfort C., Stehle P., Zumtobel V.
P-159 Safety and tolerance of a low volume, high concentrated enteral supplement provides early after major abdominal surgery.
Clinical Nutrition 2002; Vol. 21, p. 75 (Suppl. 1)
READ MORE (29 KB)
Scheppach W., Plauth M., Mühlhöfer A., Weimann A., Rubin D., Faust D., Schauber J., Stein J. and Intestamin® Study Group
P-118 Intestamin and acute pancreatitis.
Clinical Nutrition 2003; Vol. 22, p. 32 (Suppl. 1)
READ MORE (35 KB)
Senkal M., Haaker R., Deska T., Hummel T., Steinforta C., Zumtobel V., Alteheld B., Stehle P.
Early enteral gut feeding with conditionally indispensable pharmaconutrients is metabolically safe and is well tolerated in postoperative cancer patients - a pilot study.
Clinical Nutrition 2004; 23:1193-1198
READ MORE (0.1 MB)
Beale R., Sherry T., Lei K., Campbell-Stephen L., McCook J., Smith J., Neilson A., Schneider H.
Early enteral supplementation with pharmaconutrients in critically ill patients.
Crit. Care Med. 2004; 32(12)
READ MORE (0.6 MB)